share_log

中国生物制药(01177)：受托人根据限制性股份奖励计划进一步购买500万股

China Biopharmaceutical (01177): Trustee buys an additional 5 million shares under the Restricted Share Award Program

Zhitong Finance ·  Apr 15 17:01

China Biopharmaceutical (01177) issued an announcement. On April 15, 2024, the trustee made further purchases from the market...

According to the Zhitong Finance App, China Biopharmaceutical (01177) issued an announcement. On April 15, 2024, the trustee purchased an additional 5 million shares from the market and selected participants to hold them in trust according to the terms and conditions of the plan rules. The average cost per share is approximately HK$2.68.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment